The Gibson group at the University of Warwick (incl. the NanoCarb ESRs Ashfaq Ahmad and Panagiotis G. Georgiou) just published their work on the detection of SARS-COV-2 using sugars instead of antibodies.
This publication results from a collaboration with the platform company Iceni Diagnostics Ltd. and the University Hospitals Coventry and Warwickshire NHS Trust, and shows how glycans can be used to detect SARS-COV-2 in a flow-through device.
Reference: Alexander N. Baker, Sarah-Jane Richards, Sarojini Pandey, Collette S. Guy, Ashfaq Ahmad, Muhammad Hasan, Caroline I. Biggs, Panagiotis G. Georgiou, Alexander J. Zwetsloot, Anne Straube, Simone Dedola, Robert A. Field, Neil R Anderson, Marc Walker, Dimitris Grammatopoulos, and Matthew I. Gibson. Glycan-Based Flow-Through Device for the Detection of SARS-COV-2. ACS Sens. 2021. Open Access.